. . . . . . . . . "lantus is indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus important limitations of use lantus is not recommended for the treatment of diabetic ketoacidosis intravenous short acting insulin is the preferred treatment for this condition lantus is a long acting human insulin analog indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus 1 important limitations of use not recommended for treating diabetic ketoacidosis use intravenous short acting insulin instead" . . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "V3V5Mjmc2C3tR6gsm9ceOGYj/v4LdKxkB+wudhUbA+PF8QK54DJrVsZzzgFRoTjbzZgh2j8RcAqCJRWsmWZEEYf7ucxUxaa5IVUR7zLgh94TbI57Ba/plHoDEMesbyWXLTVz2HmUvQwxOFTLoEKf5xzZJLsy/ITLUC6j6atgA90=" . . "2021-06-12T13:33:51.656+02:00"^^ . . . . .